Skip to content

Nalu Medical, Inc. 71005 (UDI 00812537036090)Recalls & reported problems

Nalu Medical, Inc. · Nalu Neurostimulation Kit (Ported, Dual 8, 40 cm) · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00812537036090), received between Mar 22, 2023 and Mar 22, 2023 — classified as 1 injury.

The most frequently reported specific device problem is “Migration” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Migration1

Patient problems

  • Inadequate Pain Relief1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 22, 2023Migration; Migration

    PATIENT WAS IMPLANTED WITH THE NALU PERIPHERAL NERVE STIMULATOR ON (B)(6) 2022. DURING THE HEALING PROCESS, THE IMPLANTED PULSE GENERATOR (IPG) TILTED, WHICH CAUSED COMMUNICATION BETWEEN THE IPG AND THE EXTERNAL THERAPY DISC TO BECOME INTERMITTENT. A SURGICAL REVISION WAS PERFORMED TO CORRECT THE POSITION OF THE IPG ON (B)(6) 2023.

    Patient problems: Inadequate Pain Relief

    MAUDE report 16595770 ↗

Other Stimulator, Peripheral Nerve, Implanted (Pain Relief) devices

All Stimulator, Peripheral Nerve, Implanted (Pain Relief) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page